Literature DB >> 14588065

Clinical features and endoscopic progression of gastroesophageal reflux disease.

A Garrido Serrano1, F J Guerrero Igea, J A Lepe Jiménez, C Perianes Hernández.   

Abstract

OBJECTIVES: 1. To determine the progression of endoscopic affectation in patients with gastroesophageal reflux disease (GERD). 2. To analyze the clinical parameters associated to grade IV of esophagitis, as well as the degree of endoscopic progression.
MATERIAL AND METHODS: between 1996 and 2002, 692 patients with GERD have been followed prospectively (66% men and 33% women, with a mean age of 50.7 years). All were submitted to initial upper endoscopy, without treatment, and different clinical parameters associated to grade IV esophagitis were analyzed. During follow up, a new endoscopy was repeated in the event of symptomatic relapse, comparing the new findings with those of the initial exploration.
RESULTS: the initial endoscopy did not reveal signs of esophagitis in 49% of the patients. Grade I 11.2%, grade II 22%, grade III 8.1% and grade IV 8.7%. Multivariant analysis showed that advanced age (p <0.01), male sex (p <0.03), smoking (p <0.02) and absence of infection due to Helicobacter pylori (p <0.02) were independent factors associated to grade IV esophagitis. Throughout follow up, patients without esophagitis did not show evidence of esophagitis in successive endoscopies, and a higher grade was found in only 3 of the patients.
CONCLUSIONS: the endoscopy did not reveal signs of esophagitis in approximately half of the patients. Advanced age, male sex, smoking and absence of Helicobacter pylori are risk factors associated with severe stages of esophagitis. Patients with reflux without esophagitis did not develop inflammatory disorders during follow-up, while those with esophagitis remained in the stage of the initial diagnosis.

Entities:  

Mesh:

Year:  2003        PMID: 14588065

Source DB:  PubMed          Journal:  Rev Esp Enferm Dig        ISSN: 1130-0108            Impact factor:   2.086


  6 in total

1.  The real value of lower esophageal sphincter measurement for predicting acid gastroesophageal reflux or Barrett's esophagus.

Authors:  Oscar Alonso; Diego Hernández; Enrique Moreno; Alejandro Manrique; Almudena Moreno; Alvaro García-Sesma; Jorge Calvo
Journal:  J Gastrointest Surg       Date:  2005 Sep-Oct       Impact factor: 3.452

2.  Functional heartburn, nonerosive reflux disease, and reflux esophagitis are all distinct conditions--a debate: pro.

Authors:  Tomás Navarro-Rodriguez; Ronnie Fass
Journal:  Curr Treat Options Gastroenterol       Date:  2007-08

3.  Nonerosive Reflux Disease (NERD) - An Update.

Authors:  Tiberiu Hershcovici; Ronnie Fass
Journal:  J Neurogastroenterol Motil       Date:  2010-01-31       Impact factor: 4.924

4.  Prevalence of overweightedness in patients with gastro-esophageal reflux.

Authors:  Luca Piretta; Federico Alghisi; Fiorella Anzini; Enrico Corazziari
Journal:  World J Gastroenterol       Date:  2007-09-14       Impact factor: 5.742

5.  Proton Pump Inhibitors Diminish Barrett's Esophagus Length: Our Experience.

Authors:  Zaim Gashi; Elton Bahtiri; Arjeta Gashi; Fadil Sherifi
Journal:  Open Access Maced J Med Sci       Date:  2018-06-08

6.  The Prevalence, Risk Factors, and Clinical Correlates of Erosive Esophagitis and Barrett's Esophagus in Iranian Patients with Reflux Symptoms.

Authors:  Alireza Sharifi; Shahab Dowlatshahi; Hedieh Moradi Tabriz; Fatemeh Salamat; Omid Sanaei
Journal:  Gastroenterol Res Pract       Date:  2014-03-17       Impact factor: 2.260

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.